SPARK THERAPEUTICS, INC.

biotechnology

Filings
34
Clients
1
Total Income
Years Active
2017–2025

Filings

Year Client Period Income Expenses Doc
2025 SPARK THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination
$100,000
2025 SPARK THERAPEUTICS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$190,000
2024 SPARK THERAPEUTICS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$250,000
2024 SPARK THERAPEUTICS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$180,000
2024 SPARK THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$170,000
2024 SPARK THERAPEUTICS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$210,000
2023 SPARK THERAPEUTICS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$230,000
2023 SPARK THERAPEUTICS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$180,000
2023 SPARK THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$190,000
2023 SPARK THERAPEUTICS, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$210,000
Page 1 of 4  ·  34 filings Next

Clients Represented

ClientFilingsTotal Income
SPARK THERAPEUTICS, INC. 34

Lobbyists

NameDisclosed Prior Position
JEREMY ALLEN Health Policy Advisor, Rep. Bilirakis; Health Policy Coordinator, House Energy and Commerce Committee
KATHLEEN M. MCAULIFFE